Journal of Neurosurgery-Pediatrics

Papers
(The H4-Index of Journal of Neurosurgery-Pediatrics is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Editorial. External validation of predictive models for postoperative hydrocephalus in pediatric patients with posterior fossa tumors42
Erratum. Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement32
Erratum. Tethered spinal cord among individuals with myelomeningocele: an analysis of the National Spina Bifida Patient Registry28
Intraventricular hemorrhage volume and younger age at surgery may be risk factors for postoperative hydrocephalus after hemispherotomy in children26
Letter to the Editor. Sensitivity, specificity, and abusive head injury24
Intracranial invasive group A streptococcus: a neurosurgical emergency in children22
Letter to the Editor. Hemispherectomy after 35 years: a glimpse of the bigger picture21
Influence of the living Pareto chart and data transparency on patient outcomes in neurosurgery20
Letter to the Editor. Occipital bone mass for C1–2 intra-articular fusion19
Penetrating cerebrovascular injuries in a pediatric cohort with intracranial gunshot wounds: incidence, characterization of injury type, and clinical outcomes18
Resection of intradural spinal lesions with concomitant instrumented fusion in children: a systematic review and representative cases18
Ultra-low-field portable MRI for assessing ventricular size in pediatric hydrocephalus: a feasibility study18
Does subtotal resection ameliorate hypothalamic morbidity in pediatric craniopharyngioma? A 30-year retrospective cohort study17
External validation of the R2eD AVM scoring system to assess rupture risk in pediatric AVM patients17
Factors associated with early shunt revision within 30 days: analyses from the National Surgical Quality Improvement Program17
Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial16
0.10066390037537